Clinical Trials · NCT06301256
Evaluate the Efficacy of TIRZEPATIDE for the Treatment of Moderate to Severe HS Hidradenitis Suppurativa
- Phase
- N/A
- Recruitment status
- Unknown
- Sponsor
- Florida Academic Centers Research and Education, LLC
- Enrollment
- 20
- Start date
- Mar 2024
- Locations
- See registry
- Primary endpoint
- Hidradenitis Suppurativa Clinical Response (HiSCR) 50%